비교리스트

 카트 문의
시장보고서
상품코드
1531002

세계의 GI 대변 검사 시장 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2034년)

GI Stool Testing Market (Product Type: Consumables and Analyzers, and Test Type: Occult Blood Test, Ova and Parasites Test, Fecal Biomarkers Test, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
발행일: | 리서치사: Transparency Market Research | 페이지 정보: 영문 148 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

이 보고서는 2024-2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사하여 세계 GI 대변 검사 시장에 대해 조사했습니다. 이 보고서는 2024년을 기준 연도, 2034년을 예측 연도로 하여 2018-2034년까지의 세계 GI 대변 검사 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 GI 대변 검사 시장의 연평균 성장률(CAGR%)도 제시합니다.

이 보고서는 광범위한 조사를 통해 작성되었으며, 1차 조사에서 분석가들은 KOL(Key Opinion Leader), 업계 리더 및 오피니언 제조업체를 인터뷰하고, 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 자료 등을 참조하여 GI 대변 검사 시장을 추론했습니다.

시장 현황
2023년 시장 규모 5억 5,500만 달러
2034년 시장 규모 13억 달러
CAGR 7.7%

이 보고서는 세계 GI 대변 검사 시장의 경쟁 환경을 조사했습니다. 세계 GI 대변 검사 시장에서 사업을 전개하는 주요 업체들이 확인되었으며, 각 업체는 다양한 속성으로 프로파일링되었습니다. 기업 개요, 재무 상태, 최근 동향, SWOT 등은 이 보고서에서 소개하는 세계 GI 대변 검사 시장의 기업 속성입니다.

목차

제1장 서문

제2장 전제조건과 조사 방법

제3장 주요 요약 : 세계 시장

제4장 시장 개요

  • 서론
  • 개요
  • 시장 역학
  • 세계 시장 분석과 예측, 2020-2034년

제5장 주요 인사이트

  • 파이프라인 분석
  • 주요 제품/브랜드 분석
  • COVID-19의 산업에 대한 영향

제6장 세계 시장 분석과 예측 : 제품 유형별

  • 서론과 정의
  • 주요 조사 결과·발전
  • 시장 매출 예측 : 제품 유형별, 2020-2034년
    • 소모품
    • 애널라이저
  • 시장 매력 분석 : 제품 유형별

제7장 세계 시장 분석과 예측 : 검사 유형별

  • 서론과 정의
  • 주요 조사 결과·발전
  • 시장 매출 예측 : 검사 유형별, 2020-2034년
    • 잠혈 검사
    • 난자 및 기생충 검사
    • 분변 바이오마커 검사
    • 기타(세균 검사 등)
  • 시장 매력 분석 : 검사 유형별

제8장 세계 시장 분석과 예측 : 적응증별

  • 서론과 정의
  • 주요 조사 결과·발전
  • 시장 매출 예측 : 적응증별, 2020-2034년
    • 감염증
    • 염증성 장질환
    • 위식도 역류증
    • 암
    • 기타
  • 시장 매력 분석 : 적응증별

제9장 세계 시장 분석과 예측 : 최종사용자별

  • 서론과 정의
  • 주요 조사 결과·발전
  • 시장 매출 예측 : 최종사용자별, 2020-2034년
    • 병원
    • 진단센터 및 검사실
    • 학술기관
    • 연구센터 및 조직
    • 기타
  • 시장 매력 분석 : 최종사용자별

제10장 세계 시장 분석과 예측 : 지역별

  • 주요 조사 결과
  • 시장 매출 예측 : 지역별, 2020-2034년
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카
  • 시장 매력 분석 : 지역별

제11장 북미 시장 분석과 예측

제12장 유럽 시장 분석과 예측

제13장 아시아태평양 시장 분석과 예측

제14장 라틴아메리카 시장 분석과 예측

제15장 중동 및 아프리카 시장 분석과 예측

제16장 경쟁 구도

  • 시장 기업 - 경쟁 매트릭스(기업 Tier 및 규모별)
  • 시장 점유율 분석 : 기업별(2023년)
  • 기업 개요
    • Abbott Laboratories
    • Beckman Coulter, Inc.
    • Bio-Rad Laboratories
    • BioMerieux Inc.
    • Cardinal Health, Inc.
    • Cenogenics Corporation
    • Epitope Diagnostics, Inc.
    • ScheBo Biotech AG
    • Quest Diagnostics
    • Genova Diagnostics
LSH 24.09.04

GI Stool Testing Market - Scope of Report

TMR's report on the global GI stool testing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global GI stool testing market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global GI stool testing market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the GI stool testing market.

Market Snapshot
Market Value in 2023US$ 555 Mn
Market Value in 2034US$ 1.3 Bn
CAGR7.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global GI stool testing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global GI stool testing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global GI stool testing market.

The report delves into the competitive landscape of the global GI stool testing market. Key players operating in the global GI stool testing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global GI stool testing market profiled in this report.

Key Questions Answered in Global GI stool testing Market Report:

  • What is the sales/revenue generated by GI stool testing across all regions during the forecast period?
  • What are the opportunities in the global GI stool testing market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

GI Stool Testing Market - Research Objectives and Research Approach

The comprehensive report on the global GI stool testing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global GI stool testing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global GI stool testing market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global GI Stool Testing Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global GI Stool Testing Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global GI Stool Testing Market Analysis and Forecast, by Product Type

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2020-2034
    • 6.3.1. Consumables
    • 6.3.2. Analyzers
  • 6.4. Market Attractiveness, by Product Type

7. Global GI Stool Testing Market Analysis and Forecast, by Test Type

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Test Type, 2020-2034
    • 7.3.1. Occult Blood Test
    • 7.3.2. Ova and Parasites Test
    • 7.3.3. Fecal Biomarkers Test
    • 7.3.4. Others (Bacteria Test, etc.)
  • 7.4. Market Attractiveness, by Test Type

8. Global GI Stool Testing Market Analysis and Forecast, by Indication

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Indication, 2020-2034
    • 8.3.1. Infection
    • 8.3.2. Inflammatory Bowel Disease
    • 8.3.3. Gastroesophageal Reflux Disease
    • 8.3.4. Cancer
    • 8.3.5. Others (Poor Absorption Problems, etc.)
  • 8.4. Market Attractiveness, by Indication

9. Global GI Stool Testing Market Analysis and Forecast, by End-user

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2020-2034
    • 9.3.1. Hospitals
    • 9.3.2. Diagnostic Centers & laboratories
    • 9.3.3. Academic Institutes
    • 9.3.4. Research Centers & Organizations
    • 9.3.5. Others (Homecare Settings, etc.)
  • 9.4. Market Attractiveness, by End-user

10. Global GI Stool Testing Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2020-2034
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness, by Region

11. North America GI Stool Testing Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2020-2034
    • 11.2.1. Consumables
    • 11.2.2. Analyzers
  • 11.3. Market Attractiveness, by Product Type
  • 11.4. Market Value Forecast, by Test Type, 2020-2034
    • 11.4.1. Occult Blood Test
    • 11.4.2. Ova and Parasites Test
    • 11.4.3. Fecal Biomarkers Test
    • 11.4.4. Others (Bacteria Test, etc.)
  • 11.5. Market Attractiveness, by Test Type
  • 11.6. Market Value Forecast, by Indication, 2020-2034
    • 11.6.1. Infection
    • 11.6.2. Inflammatory Bowel Disease
    • 11.6.3. Gastroesophageal Reflux Disease
    • 11.6.4. Cancer
    • 11.6.5. Others (Poor Absorption Problems, etc.)
  • 11.7. Market Attractiveness, by Indication
  • 11.8. Market Value Forecast, by End-user, 2020-2034
    • 11.8.1. Hospitals
    • 11.8.2. Diagnostic Centers & laboratories
    • 11.8.3. Academic Institutes
    • 11.8.4. Research Centers & Organizations
    • 11.8.5. Others (Homecare Settings, etc.)
  • 11.9. Market Attractiveness, by End-user
  • 11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.10.1. U.S.
    • 11.10.2. Canada
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Product Type
    • 11.11.2. By Test Type
    • 11.11.3. By Indication
    • 11.11.4. By End-user
    • 11.11.5. By Country

12. Europe GI Stool Testing Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2020-2034
    • 12.2.1. Consumables
    • 12.2.2. Analyzers
  • 12.3. Market Attractiveness, by Product Type
  • 12.4. Market Value Forecast, by Test Type, 2020-2034
    • 12.4.1. Occult Blood Test
    • 12.4.2. Ova and Parasites Test
    • 12.4.3. Fecal Biomarkers Test
    • 12.4.4. Others (Bacteria Test, etc.)
  • 12.5. Market Attractiveness, by Test Type
  • 12.6. Market Value Forecast, by Indication, 2020-2034
    • 12.6.1. Infection
    • 12.6.2. Inflammatory Bowel Disease
    • 12.6.3. Gastroesophageal Reflux Disease
    • 12.6.4. Cancer
    • 12.6.5. Others (Poor Absorption Problems, etc.)
  • 12.7. Market Attractiveness, by Indication
  • 12.8. Market Value Forecast, by End-user, 2020-2034
    • 12.8.1. Hospitals
    • 12.8.2. Diagnostic Centers & laboratories
    • 12.8.3. Academic Institutes
    • 12.8.4. Research Centers & Organizations
    • 12.8.5. Others (Homecare Settings, etc.)
  • 12.9. Market Attractiveness, by End-user
  • 12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.10.1. Germany
    • 12.10.2. U.K.
    • 12.10.3. France
    • 12.10.4. Italy
    • 12.10.5. Spain
    • 12.10.6. Rest of Europe
  • 12.11. Market Attractiveness Analysis
    • 12.11.1. By Product Type
    • 12.11.2. By Test Type
    • 12.11.3. By Indication
    • 12.11.4. By End-user
    • 12.11.5. By Country/Sub-region

13. Asia Pacific GI Stool Testing Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2020-2034
    • 13.2.1. Consumables
    • 13.2.2. Analyzers
  • 13.3. Market Attractiveness, by Product Type
  • 13.4. Market Value Forecast, by Test Type, 2020-2034
    • 13.4.1. Occult Blood Test
    • 13.4.2. Ova and Parasites Test
    • 13.4.3. Fecal Biomarkers Test
    • 13.4.4. Others (Bacteria Test, etc.)
  • 13.5. Market Attractiveness, by Test Type
  • 13.6. Market Value Forecast, by Indication, 2020-2034
    • 13.6.1. Infection
    • 13.6.2. Inflammatory Bowel Disease
    • 13.6.3. Gastroesophageal Reflux Disease
    • 13.6.4. Cancer
    • 13.6.5. Others (Poor Absorption Problems, etc.)
  • 13.7. Market Attractiveness, by Indication
  • 13.8. Market Value Forecast, by End-user, 2020-2034
    • 13.8.1. Hospitals
    • 13.8.2. Diagnostic Centers & laboratories
    • 13.8.3. Academic Institutes
    • 13.8.4. Research Centers & Organizations
    • 13.8.5. Others (Homecare Settings, etc.)
  • 13.9. Market Attractiveness, by End-user
  • 13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.10.1. China
    • 13.10.2. Japan
    • 13.10.3. India
    • 13.10.4. Australia & New Zealand
    • 13.10.5. Rest of Asia Pacific
  • 13.11. Market Attractiveness Analysis
    • 13.11.1. By Product Type
    • 13.11.2. By Test Type
    • 13.11.3. By Indication
    • 13.11.4. By End-user
    • 13.11.5. By Country/Sub-region

14. Latin America GI Stool Testing Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2020-2034
    • 14.2.1. Consumables
    • 14.2.2. Analyzers
  • 14.3. Market Attractiveness, by Product Type
  • 14.4. Market Value Forecast, by Test Type, 2020-2034
    • 14.4.1. Occult Blood Test
    • 14.4.2. Ova and Parasites Test
    • 14.4.3. Fecal Biomarkers Test
    • 14.4.4. Others (Bacteria Test, etc.)
  • 14.5. Market Attractiveness, by Test Type
  • 14.6. Market Value Forecast, by Indication, 2020-2034
    • 14.6.1. Infection
    • 14.6.2. Inflammatory Bowel Disease
    • 14.6.3. Gastroesophageal Reflux Disease
    • 14.6.4. Cancer
    • 14.6.5. Others (Poor Absorption Problems, etc.)
  • 14.7. Market Attractiveness, by Indication
  • 14.8. Market Value Forecast, by End-user, 2020-2034
    • 14.8.1. Hospitals
    • 14.8.2. Diagnostic Centers & laboratories
    • 14.8.3. Academic Institutes
    • 14.8.4. Research Centers & Organizations
    • 14.8.5. Others (Homecare Settings, etc.)
  • 14.9. Market Attractiveness, by End-user
  • 14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.10.1. Brazil
    • 14.10.2. Mexico
    • 14.10.3. Rest of Latin America
  • 14.11. Market Attractiveness Analysis
    • 14.11.1. By Product Type
    • 14.11.2. By Test Type
    • 14.11.3. By Indication
    • 14.11.4. By End-user
    • 14.11.5. By Country/Sub-region

15. Middle East & Africa GI Stool Testing Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product Type, 2020-2034
    • 15.2.1. Consumables
    • 15.2.2. Analyzers
  • 15.3. Market Attractiveness, by Product Type
  • 15.4. Market Value Forecast, by Test Type, 2020-2034
    • 15.4.1. Occult Blood Test
    • 15.4.2. Ova and Parasites Test
    • 15.4.3. Fecal Biomarkers Test
    • 15.4.4. Others (Bacteria Test, etc.)
  • 15.5. Market Attractiveness, by Test Type
  • 15.6. Market Value Forecast, by Indication, 2020-2034
    • 15.6.1. Infection
    • 15.6.2. Inflammatory Bowel Disease
    • 15.6.3. Gastroesophageal Reflux Disease
    • 15.6.4. Cancer
    • 15.6.5. Others (Poor Absorption Problems, etc.)
  • 15.7. Market Attractiveness, by Indication
  • 15.8. Market Value Forecast, by End-user, 2020-2034
    • 15.8.1. Hospitals
    • 15.8.2. Diagnostic Centers & laboratories
    • 15.8.3. Academic Institutes
    • 15.8.4. Research Centers & Organizations
    • 15.8.5. Others (Homecare Settings, etc.)
  • 15.9. Market Attractiveness, by End-user
  • 15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 15.10.1. GCC Countries
    • 15.10.2. South Africa
    • 15.10.3. Rest of Middle East & Africa
  • 15.11. Market Attractiveness Analysis
    • 15.11.1. By Product Type
    • 15.11.2. By Test Type
    • 15.11.3. By Indication
    • 15.11.4. By End-user
    • 15.11.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2023)
  • 16.3. Company Profiles
    • 16.3.1. Abbott Laboratories
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Beckman Coulter, Inc.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Bio-Rad Laboratories
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. BioMerieux Inc.
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Cardinal Health, Inc.
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Cenogenics Corporation
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Epitope Diagnostics, Inc.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. ScheBo Biotech AG
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Quest Diagnostics
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Genova Diagnostics
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제